FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of MedicineMay 11, 201110.1056/nejmoa1011923Cited by 7,761SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis